Mirtazapine

米氮平

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameMirtazapine
Drug Alias NameRexer米他扎品Mirtazapinum米塔扎平米尔塔扎平 +[22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 antagonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsDepressive Disorder, MajorDepressionHeroin Dependence +[21
Global Approved IndicationsDepressive Disorder, MajorDepression
Approved Indications in ChinaDepression
Original Approved Country/TerritoryNetherlands
Original Approved Date1994/03/01
Country/TerritoryCanadaUnited StatesThailand +[15
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsDepressive Disorder, MajorDepressionSubstance-Related Disorders +[9
Inactive IndicationsHeroin DependenceCocaine-Related DisordersAmphetamine-Related Disorders +[12

Other Information

ATC CodeN06AX11